Wellgistics Health Inc(US:WGRX) Globenewswire·2025-10-22 10:05Core Insights - The partnership between DataVault AI and Wellgistics aims to digitize the U.S. prescription drug market, valued at $634.32 billion, through blockchain-enabled smart contracts to enhance efficiency and transparency in drug distribution [1][2][3] Company Overview - DataVault AI specializes in AI-driven data experiences and monetization, leveraging patented technologies to innovate across various industries, including healthcare [4][5] - Wellgistics Health focuses on improving medication delivery from manufacturers to patients, utilizing an integrated platform that connects over 6,500 pharmacies and 200 manufacturers [6] Strategic Partnership - The collaboration will implement the PharmacyChain™ platform, which seeks to ensure accurate tracking of prescription drugs from the point of prescription to fulfillment, enhancing patient safety and compliance [1][2] - The companies plan to establish a revenue-sharing model based on fees from pharmacies utilizing the PharmacyChain technology [1][3] Technological Innovations - Wellgistics has introduced HubRx AI, an AI engine designed to optimize pharmacy operations, reduce costs, and improve patient outcomes while maintaining compliance with healthcare regulations [2][3] - The integration of various technological tools, including Einstein Rx AI and Wellgistics Hub, aims to enhance the overall efficiency of prescription drug services [2] Market Impact - The implementation of blockchain technology is expected to minimize administrative burdens, improve patient access to medications, and enhance the overall prescription ecosystem [3] - The partnership is positioned to create a scalable opportunity that aligns financial incentives with improved patient outcomes across the healthcare spectrum [2][3]